Drug Profile
Buprenorphine/naloxone - Indivior
Alternative Names: Buprenorphine hemiadipate HCl/naloxone HCl dihydrate; Buprenorphine hemiadipate hydrochloride/naloxone hydrochloride dihydrate; RBP-6300Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Reckitt Benckiser Pharmaceuticals
- Developer Indivior
- Class Antidotes; Benzofurans; Cyclopropanes; Drug withdrawal therapies; Isoquinolines; Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Opioid-related disorders